• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

熔融制粒技术制备的海藻酸钠-壳聚糖缓释微丸。

Sustained-release alginate-chitosan pellets prepared by melt pelletization technique.

机构信息

Particle Design Research Group, Faculty of Pharmacy, Puncak Alam, Selangor, Malaysia.

出版信息

Drug Dev Ind Pharm. 2012 Dec;38(12):1417-27. doi: 10.3109/03639045.2011.653364. Epub 2012 Feb 7.

DOI:10.3109/03639045.2011.653364
PMID:22309449
Abstract

CONTEXT

Alginate-chitosan pellets prepared by extrusion-spheronization technique exhibited fast drug dissolution.

OBJECTIVE

This study aimed to design sustained-release alginate pellets through rapid in situ matrix coacervation by chitosan during dissolution.

METHODS

Pellets made of alginate with chitosan and/or calcium acetate were prepared using solvent-free melt pelletization technique which prevented reaction between processing materials during agglomeration and allowed such reaction to occur only in dissolution phase.

RESULTS

Drug release was retarded in pH 2.2 medium when pellets were formulated with calcium acetate or chitosan till a change in medium pH to 6.8. The sustained-release characteristics of calcium alginate pellets were attributed to pellet dispersion and rapid cross-linking by soluble Ca(2+) during dissolution. The slow drug release characteristics of alginate-chitosan pellets were attributed to polyelectrolyte complexation and pellet aggregation into swollen structures with reduced erosion. The drug release was, however, not retarded when both calcium acetate and chitosan coexisted in the same matrix as a result of chitosan shielding of Ca(2+) to initiate alginate cross-linkages and rapid in situ solvation of calcium acetate induced fast pellet dispersion and chitosan losses from matrix.

CONCLUSION

Similar to calcium alginate pellets, alginate-chitosan pellets demonstrated sustained drug release property though via different mechanisms. Combination of alginate, chitosan and calcium acetate in the same matrix nevertheless failed to retard drug release via complementary drug release pattern.

摘要

背景

通过挤出成球技术制备的海藻酸盐-壳聚糖微球具有快速药物释放的特点。

目的

本研究旨在通过壳聚糖在溶解过程中的快速原位基质共凝聚来设计海藻酸盐的缓释微球。

方法

采用无溶剂熔融造粒技术制备海藻酸盐与壳聚糖和/或醋酸钙制成的微球,该技术防止了团聚过程中加工材料之间的反应,并允许这种反应仅在溶解相中发生。

结果

当微球中含有醋酸钙或壳聚糖时,在 pH 2.2 的介质中药物释放会延迟,直到介质的 pH 值变化到 6.8。海藻酸钙微球的缓释特性归因于在溶解过程中可溶的 Ca(2+)引起的微球分散和快速交联。海藻酸盐-壳聚糖微球的缓慢药物释放特性归因于聚电解质络合和微球聚集到膨胀结构中,从而减少了侵蚀。然而,当醋酸钙和壳聚糖同时存在于同一基质中时,药物释放并没有延迟,这是由于壳聚糖屏蔽 Ca(2+)以引发海藻酸盐交联,并快速原位溶解醋酸钙诱导微球快速分散和壳聚糖从基质中损失。

结论

与海藻酸钙微球类似,海藻酸盐-壳聚糖微球通过不同的机制表现出持续的药物释放特性。然而,在同一基质中结合海藻酸盐、壳聚糖和醋酸钙并没有通过互补的药物释放模式来延迟药物释放。

相似文献

1
Sustained-release alginate-chitosan pellets prepared by melt pelletization technique.熔融制粒技术制备的海藻酸钠-壳聚糖缓释微丸。
Drug Dev Ind Pharm. 2012 Dec;38(12):1417-27. doi: 10.3109/03639045.2011.653364. Epub 2012 Feb 7.
2
Design of in situ dispersible and calcium cross-linked alginate pellets as intestinal-specific drug carrier by melt pelletization technique.熔融造粒技术制备可在肠道中分散和交联的海藻酸钙微丸作为肠道特异性药物载体
J Pharm Sci. 2011 Jun;100(6):2248-57. doi: 10.1002/jps.22459. Epub 2011 Jan 6.
3
Coatless alginate pellets as sustained-release drug carrier for inflammatory bowel disease treatment.无包衣海藻酸钙微丸作为炎症性肠病治疗的缓释药物载体。
Carbohydr Polym. 2016 Nov 5;152:370-381. doi: 10.1016/j.carbpol.2016.07.021. Epub 2016 Jul 7.
4
Drug release, preclinical and clinical pharmacokinetics relationships of alginate pellets prepared by melt technology.通过熔融技术制备的海藻酸盐微丸的药物释放、临床前和临床药代动力学关系。
Expert Opin Drug Deliv. 2016;13(1):143-54. doi: 10.1517/17425247.2015.1080686. Epub 2015 Aug 24.
5
Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.壳聚糖-海藻酸盐作为微晶纤维素在挤出/滚圆法中替代制粒助剂的应用。
J Pharm Sci. 2007 Sep;96(9):2469-84. doi: 10.1002/jps.20855.
6
The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.壳聚糖、海藻酸钠及制剂变量对通过挤出滚圆法制备的微丸的形成及药物释放的影响。
Int J Pharm. 2004 May 4;275(1-2):41-60. doi: 10.1016/j.ijpharm.2004.01.025.
7
Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: in vitro characteristics and in vivo evaluation.载芦丁壳聚糖微丸治疗炎症性肠病的体外特性和体内评价。
Int J Pharm. 2012 Jan 17;422(1-2):151-9. doi: 10.1016/j.ijpharm.2011.10.045. Epub 2011 Nov 3.
8
Alginate-based pellets prepared by extrusion/spheronization: effect of the amount and type of sodium alginate and calcium salts.通过挤出/滚圆法制备的藻酸盐基微丸:海藻酸钠和钙盐的用量及类型的影响
Eur J Pharm Biopharm. 2008 May;69(1):274-84. doi: 10.1016/j.ejpb.2007.09.012. Epub 2007 Sep 29.
9
Immersion coating of pellet cores consisting of chitosan and calcium intended for colon drug delivery.球芯的浸渍涂层,由壳聚糖和钙组成,用于结肠药物传递。
Eur J Pharm Biopharm. 2010 Jun;75(2):245-53. doi: 10.1016/j.ejpb.2010.02.012. Epub 2010 Feb 25.
10
Alginate-based pellets prepared by extrusion/spheronization: a preliminary study on the effect of additive in granulating liquid.通过挤出/滚圆法制备的海藻酸盐微丸:关于制粒液中添加剂作用的初步研究
Eur J Pharm Biopharm. 2007 Aug;67(1):227-35. doi: 10.1016/j.ejpb.2006.11.007. Epub 2006 Nov 23.

引用本文的文献

1
Formulation and Evaluation of Microwave-Modified Chitosan-Curcumin Nanoparticles-A Promising Nanomaterials Platform for Skin Tissue Regeneration Applications Following Burn Wounds.微波改性壳聚糖-姜黄素纳米粒子的制备与评价——一种用于烧伤创面后皮肤组织再生应用的有前景的纳米材料平台
Polymers (Basel). 2020 Nov 6;12(11):2608. doi: 10.3390/polym12112608.
2
In Vitro Investigation of Influences of Chitosan Nanoparticles on Fluorescein Permeation into Alveolar Macrophages.壳聚糖纳米颗粒对荧光素渗透进入肺泡巨噬细胞影响的体外研究
Pharm Res. 2016 Jun;33(6):1497-508. doi: 10.1007/s11095-016-1893-5. Epub 2016 Mar 7.